3 Biotech Stocks That Could Pop in a Heartbeat – InvestorPlace

View All3 Biotech Stocks That Could Pop in a HeartbeatBiotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months.Click to Enlarge And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For […]

Despite Stock Market Highs, 13 Major Dividend Cuts – 24/7 Wall St.

Investors have a lot to cheer about these days. The bull market is now six years old, the major stock market averages have hit new all-time highs, and most major companies seem to be raising their dividends year after year. That is the case for most companies, but certainly not all. In fact, some major outfits have been forced to lower their […]

Was Gilead Sciences Inc.'s Dividend a Good Idea?

Source: Gilead Sciences.Gilead Sciences surprised investors when it recently announced that it will begin returning some of its cash stockpile to investors in the form of a dividend. Since dividend-paying biotech stocks are a bit of a rarity, we asked two Motley Fool healthcare experts for their opinion on whether Gilead Sciences’ dividend plan makes sense. Read on to learn […]

The Bear Case for Stocks – Barron's

U.S. stocks have been sputtering this year following a sixth straight year of positive performance in 2014.
But can things take a true turn for the worse? Several articles make the case for why a correction or even a bear market could be around the corner.
A few months ago, many market stories argued that stocks would be taken down by a […]

Freeport Earnings Preview: Stock Trading Below Tangible Book …

SummaryFCX trading below tangible book value.
The stock has a 6% dividend yield at its current price.
Indonesia continues to be a giant thorn in the side of Freeport management.
Dividend may not be sustainable.
Either capex or the dividend needs to be reduced, after examining free-cash-flow.
Freeport-McMoRan (NYSE:FCX) kicks off the Basic Materials festivities Tuesday morning, January 27th, 2015, releasing their 4th quarter, 2014 […]

Stocks To Watch For July 25, 2014 | Benzinga

Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
Top 4 Stocks In The Technical Services Industry With The Highest Dividend Yield

Benzinga’s M&A Chatter for Thursday July 24, 2014


Stocks To Watch For July 25, 2014 | Benzinga

See which stocks are being affected by Social Media


They're Lying to Us, Part 3: The Fake Stock Market

For the average person trying to decide how to feel about the economy, the single biggest data point is the stock market. When share prices are rising, the implicit message is that finance professionals — who, after all, dedicate their lives to understanding such things and should therefore know what’s happening — have decided that life is good and getting […]

Traders worry big divergence in stock market is warning – CNBC.com

The small cap Russell 2000 was slightly higher, after finishing down 2 points at 1,105 Wednesday, below its 200-day moving average for a second day. Whether the Russell 2000 is a red flag for the broader market or not, it could continue to feel the heat as investors trim positions in momentum and small cap names. Stocks […]

What Stock Market? These Dividend Contenders Are Not …

IntroductionIt has become vividly clear to me that many investors continue to believe that the stock market in general is currently overvalued. Some even go as far to say that it is currently in bubble territory. Although I disagree, (my views about the valuation level of the stock market as measured by the S&P 500 can be found in the […]

Putting Biotech Stocks Under the Microscope – Barron's – Barrons.com

In 1996, fresh out Harvard, Rajiv Kaul went to work as an analyst covering biotechnology at Fidelity Investments. At the time, the sector was still considered a risky niche—the perfect project for the new guy. “Biotech was viewed like a lottery ticket,” says Kaul, 41. “It was something conventional investors shied away from.”
Where others saw uncertainty, Kaul saw possibility. After […]